Acepromazine Maleate

Verify with FDA CVM →

1,034 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
1,034
Total Reports
219
Deaths Reported
2120.0%
Death Rate

Active Ingredients

Acepromazine Maleate

Administration Routes

UnknownIntramuscularOralSubcutaneousIntravenousIntraperitonealOphthalmicTransdermalOtherParenteral

Species Affected

Dog 732
Cat 193
Unknown 62
Horse 30
Human 5
Cattle 5
Mouse 3
Rabbit 2
Pig 1
Other Rodents 1

Most Affected Breeds

Domestic Shorthair 107
Retriever - Labrador 100
Dog (unknown) 73
Unknown 67
Chihuahua 39
Crossbred Canine/dog 28
Shepherd Dog - German 27
Terrier - Bull - American Pit 22
Retriever - Golden 21
Cat (other) 19

Most Reported Reactions

Vomiting 137
Lethargy (see also Central nervous system depression in 'Neurological') 117
Death 109
Death by euthanasia 80
Anorexia 75
Diarrhoea 56
Other abnormal test result NOS 55
Lack of efficacy - NOS 53
Seizure NOS 51
Bradycardia 50
Elevated alanine aminotransferase (ALT) 49
Cardiac arrest 47

Outcome Breakdown

Recovered/Normal
327 (35.0%)
Ongoing
276 (29.6%)
Died
124 (13.3%)
Outcome Unknown
109 (11.7%)
Euthanized
96 (10.3%)
Recovered with Sequela
2 (0.2%)

Data Summary

Metric Value
Total adverse event reports 1,034
Reports involving death 219
Case-fatality rate (reported events) 2120.0%
Distinct species in reports 10
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Acepromazine Maleate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 1,034 adverse event reports referencing Acepromazine Maleate, including 219 reports in which the animal died — a 2120.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Acepromazine Maleate. Reported administration routes include Unknown, Intramuscular, Oral, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Acepromazine Maleate reports are Dog (732 reports), Cat (193 reports), Unknown (62 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (107), Retriever - Labrador (100), Dog (unknown) (73) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Acepromazine Maleate are Vomiting (137), Lethargy (see also Central nervous system depression in 'Neurological') (117), Death (109), Death by euthanasia (80). Of the 934 reports with a coded outcome, Recovered/Normal is the leading category at 35.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Acepromazine Maleate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial